Meridian Bioscience Inc.

NASDAQ: VIVO · Real-Time Price · USD
33.97
0.00 (0.00%)
At close: Jan 30, 2023, 10:00 PM

Meridian Bioscience Ratios and Metrics

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2022 FY 2021
Period Ending Sep 30, 2022 Sep 30, 2021
PE Ratio
32.68 11.86
PEG Ratio
-0.8 0.23
PS Ratio
4.17 2.66
PB Ratio
3.77 2.58
P/FCF Ratio
18.82 17.44
P/OCF Ratio
16.85 12.66
OCF/S Ratio
0.25 0.21
Debt / Equity Ratio
0.08 0.20
Quick Ratio
2.46 2.46
Current Ratio
3.63 4.09
Asset Turnover
0.72 0.71
Interest Coverage
46.68 49.54
Return on Equity
0.12 0.22
Return on Assets
0.09 0.16
Return on Invested Capital
0.11 0.18
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
0.57 0.63
Net Profit Margin
0.13 0.22
Pretax Profit Margin
0.16 0.28
Operating Profit Margin
0.17 0.29
FCF Margin
n/a n/a
EBITDA Margin
0.22 0.34